Hainan Honz Pharmaceutical Co Asset Resilience Ratio

Latest as of June 2021: 0.27%

Hainan Honz Pharmaceutical Co asset resilience ratio. Hainan Honz Pharmaceutical Co (300086) has an Asset Resilience Ratio of 0.27% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hainan Honz Pharmaceutical Co (300086) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥7.01 Million

≈ $1.03 Million USD Cash + Short-term Investments

Total Assets

CN¥2.58 Billion

≈ $377.59 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Hainan Honz Pharmaceutical Co (2014–2019)

Asset resilience ratio of Hainan Honz Pharmaceutical Co from 2014 to 2019. This chart shows how Hainan Honz Pharmaceutical Co's Asset Resilience Ratio has changed over time. Read 300086 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hainan Honz Pharmaceutical Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 300086 total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥7.01 Million	0.27%
Total Liquid Assets	CN¥7.01 Million	0.27%

Asset Resilience Insights

Limited Liquidity: Hainan Honz Pharmaceutical Co maintains only 0.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Hainan Honz Pharmaceutical Co Industry Peers by Asset Resilience Ratio

Compare Hainan Honz Pharmaceutical Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Hainan Honz Pharmaceutical Co Asset Resilience Ratio by Year (2014–2019)

Hainan Honz Pharmaceutical Co asset resilience ratio by year from 2014 to 2019. The table below shows the annual Asset Resilience Ratio data for Hainan Honz Pharmaceutical Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	0.94%	CN¥20.53 Million ≈ $3.00 Million	CN¥2.19 Billion ≈ $321.11 Million	+0.30pp
2017-12-31	0.63%	CN¥14.15 Million ≈ $2.07 Million	CN¥2.24 Billion ≈ $327.19 Million	-0.71pp
2016-12-31	1.34%	CN¥29.36 Million ≈ $4.30 Million	CN¥2.19 Billion ≈ $320.39 Million	-44.24pp
2015-12-31	45.58%	CN¥952.50 Million ≈ $139.38 Million	CN¥2.09 Billion ≈ $305.81 Million	+42.98pp
2014-12-31	2.59%	CN¥50.00 Million ≈ $7.32 Million	CN¥1.93 Billion ≈ $282.00 Million	--

pp = percentage points

About Hainan Honz Pharmaceutical Co

SHE:300086 China Drug Manufacturers - Specialty & Generic

Market Cap

$319.01 Million

CN¥2.18 Billion CNY

Market Cap Rank

#14259 Global

#4211 in China

Share Price

CN¥4.79

Change (1 day)

+1.48%

52-Week Range

CN¥4.62 - CN¥13.71

All Time High

CN¥17.75